Europe Medical Polymers Market Size & Outlook, 2022-2030
Europe medical polymers market, 2019-2030 (US$M)
Related Markets
Europe medical polymers market highlights
- The Europe medical polymers market generated a revenue of USD 5,256.9 million in 2022.
- The market is expected to grow at a CAGR of 7.8% from 2023 to 2030.
- In terms of segment, fibers & resins was the largest revenue generating product in 2022.
- Biodegradable Polymers is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 5,256.9 million |
| Market revenue in 2030 | USD 9,567.0 million |
| Growth rate | 7.8% (CAGR from 2022 to 2030) |
| Largest segment | Fibers & resins |
| Fastest growing segment | Biodegradable Polymers |
| Historical data covered | 2019 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fibers & Resins, Medical Elastomers, Biodegradable Polymers |
| Key market players worldwide | Basf SE, Cargill, Covestro AG, Celanese Corp Class A, Eastman Chemical Co, Evonik Industries AG, Dow Inc, Exxon Mobil Corp, Arkema SA, Koninklijke DSM NV, Formosa Plastics Group, SABIC, Trinseo PLC |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.4% of the global medical polymers market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,188.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Polymers Market Scope
Medical Polymers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe medical polymers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical polymers market will help companies and investors design strategic landscapes.
Fibers & resins was the largest segment with a revenue share of 80.2% in 2022. Horizon Databook has segmented the Europe medical polymers market based on fibers & resins, medical elastomers, biodegradable polymers covering the revenue growth of each sub-segment from 2019 to 2030.
An increasing geriatric population and rising occurrence of chronic diseases in the region have augmented the demand for medical devices. This is expected to drive the demand for medical polymers in equipment manufacturing over the forecast period.
Increasing government investments on the healthcare sector and the growing home healthcare market are anticipated to drive the demand for medical devices, which, in turn, is expected to have a positive influence on the medical polymers market over the forecast period.
Revision of the regulatory framework associated with the medical device industry is expected to increase the safety and performance standards of medical devices. As a result, the demand for innovative, biocompatible, and recyclable polymers with superior quality is expected to grow in the coming years.
Reasons to subscribe to Europe medical polymers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe medical polymers market databook
-
Our clientele includes a mix of medical polymers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe medical polymers market , including forecasts for subscribers. This continent databook contains high-level insights into Europe medical polymers market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe medical polymers market size, by country, 2019-2030 (US$M)
Europe Medical Polymers Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
